Neonious Biotech

Neonious Biotech

Created using Figma
Created using Figma
Neonious Biotech is introducing the Neonious Token (MDSIM) which is intended to incentivize large numbers of people to form the Neonious Network, a group of computers which will perform the molecular dynamics simulations, by distributing newly generated MDSIMs among these people based on the computing power they provide to the cause. With the molecular dynamics simulations, Neonious Biotech will power Alzheimer and dementia research.
Pre-ICO
May 25, 2021
Aug 31, 2021
28% completed
Raised funds - no Data
Goal 250 000.00 USD
Cap 30 000 000.00 USD
ongoing
  • 1 MDSIM
    =
    0.1 USD
Token Details
Ticker
MDSIM
Total supply
125000000
Token Distribution
80% Token Sale
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
Accepted Currencies
ETH, USDC
Min Contribution
250000
USD
Company Details
Registered Company Name
Neonious Biotech
Registered Country
Germany
Bonus Structure
The price per token starts at 0.10 USD and will, as a minimum, increase by 0.01 USD after every 250,000 ordered tokens, making it worthwhile to buy early.
Additional Details
MVP/Prototype
Yes
Platform
Ethereum
Categories
Platform

Technical Info

https://github.com/neonious/WelcomeToCodeRepository

Neonious Biotech Roadmap

  • 25/05/2021

  • Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
    ordered, the cheaper the tokens are.
  • 01/07/2021

  • Extensively tested Neonious MD software available on GitHub (source code) and for
    download (Windows, macOS and Linux). May be used on testing network to generate new
    testing tokens.
  • 01/09/2021

  • Neonious MD software and mining contract passed security audit, results are published.
    Neonious Biotech starts the full ICO, preferably with a major exchange.
  • 31/10/2021

  • Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
    anyone on Uniswap by setting up an adequate liquidity pool.
  • Read More
  • 01/11/2021

  • Neonious Biotech will start helping people set up their systems with the Neonious MD
    software to scale the Neonious Network.
  • 01/01/2022

  • Start of actual molecular dynamic simulations targeting dementia.
  • Early 2022

  • We plan to have reached an agreement for the Neonious Token to be listed at a major
    exchange.

Activity

Followers:
170
VERY LOW
Tweets:
20
VERY LOW
30 Days Growth:
3
Alexa

Rank:
5 954 619
VERY LOW
Delta:
0
Year commits:
878
Watchers:
73
Stars:
1 236
Forks:
80
Open issues:
53

Neonious Biotech Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Thomas Rogg
Chief Executive Officer & Head of Development Team
unverified
Elena Elgina
Head of PR & Marketing
unverified
Maria Cristina Fadgy...
Head of Scientific Affairs
unverified
Martin Kämpf
Head of Digital Assets
unverified

Neonious Biotech Last News

  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.